Profilo
Henry M.
Dachowitz has been a Director of Lev Pharmaceuticals, Inc. since November 28, 2007 and an Independent Financial and Business Management Consultant since 2006.
He was Treasurer of Nassau County New York.
Mr. Dachowitz was an Auditor of Coopers & Lybrand, a Research Analyst with Sanford C.
Bernstein & Company and Chief Financial Officer of Pharmos Corporation.
He was a Member of the Student Advisory Committee of the Institute of Politics at the Kennedy School of Government at Harvard University and an Editorial Advisor of the Journal of Accountancy from 1989 to 1999.
Mr. Dachowitz is a Certified Public Accountant and received a Bachelor of Science degree from Brooklyn College and a Masters in Business Administration from Harvard Business School.
Precedenti posizioni note di Henry M. Dachowitz
| Società | Posizione | Fine |
|---|---|---|
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Direttore/Membro del Consiglio | 22/10/2008 |
Formazione di Henry M. Dachowitz
| Brooklyn College | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Health Technology |
- Borsa valori
- Insiders
- Henry M. Dachowitz
